Sensex, Nifty Close Higher After Two-Week Rout

Indian equity benchmarks rebounded from its two back-to-back weekly declines in more than four months as stocks gained across Asia.

The S&P BSE Sensex Index closed 0.9 percent higher at 34,300.47, while the NSE Nifty closed 0.8 percent higher at 10,539.75.

The market breadth was tilted in favour of buyers. Seventeen out of 19 sector gauges compiled by BSE Ltd. rose, led by S&P BSE Power Index's 1.9 percent gain. On the flipside, S&P BSE Information Technology was the top sectoral loser, down 0.4 percent.

Key highlights from the conversation:

• Expect to maintain rising revenue trend going ahead.
• Month on month books on demand business is growing.
• Had close to 5 crore books on demand for January.
• Input costs are a pass through costs which are transferred to publishers.
• Will consolidate traditional business into one unit in Gujarat.
• Books on demand business generated a business of Rs 3.5 crore.
• Hopeful of maintaining 14.5 percent margins in the coming quarter.
• Not focusing on improving margins, will be happy to maintain.
• Planned Rs 30 crore capex plan in books on demand business for the next 6-9 months.
• Cost of material has gone up.

Key highlights from the conversation:

• Have funded all our capacity expansion by internal accruals & believe this to continue.
• No plans of fund raising as of now.
• Debt-to-equity stands at 0.14 times currently.
• Sustaining 20 percent Ebitda margins will not be a problem at all.
• Orders from key clients like toyota, tata motors will improve growth prospects.
• Have been able to sustain 20 percent Ebitda margins till now.
• 80 percent capacity utilisation currently.
• Gujarat plant likely to commence full-fledged production by June.
• Chennai plant now ready to cater to customers.
• Maintenance shut down with key clients like Maruti impacted Q3 results.
• Brownfield expansion plan is almost complete.

Future Enterprises swings to profit for the first time in six quarters during October-December period. The stock rose as much as 14.5 percent to Rs 47.85 after the earnings announcement.

Key Earnings Highlights Q3 (YoY)

• Net profit at Rs 82 crore versus net loss of Rs 37 crore.
• Revenue rose 15.5 percent to Rs 1,091.4 crore.
• Ebitda rose 18.6 percent to Rs 275 crore.
• Margin expanded to 25.2 percent versus 24.6 percent.

Shares of the power supplier rose as much as 3.5 percent to Rs 467.40. The company received approval from Competition Commission of India for the sale of its Mumbai power business to Adani Transmission, according to its stock exchange notification.

The company expects to complete the transaction by March, the statement added.

The stock is 32 percent below the Bloomberg consensus one-year rice target. It declined 17 percent since the beginning of the year.

Shares of the Chennai-based lender rose as much as 7.5 percent, the most since Nov. 9, 2017, to Rs 364.90. The bank's asset quality improved during October-December period.

Key Earnings Highlights Q3 (YoY)

• Net profit declined 18.8 percent to Rs 303 crore.
• Net interest income rose 30.2 percent to Rs 1,622.7 crore.
• Gross NPA in absolute terms at Rs 9,595 crore versus Rs 9,624 crore (QoQ).
• Net NPA in absolute terms at Rs 4,898.6 crore versus Rs 4,748.2 crore (QoQ).
• Provisions at Rs 918 crore versus Rs 744.5 crore (QoQ).
• Gross NPA At 6.27 percent versus 6.67 percent (QoQ).

Shares of the electrical equipment maker rose as much as 4.4 percent, the most in a one-and-a-half month to Rs 92. The company won $55 million order form Indonesian State Utility for manufacturing and supply of 64 units of Power Transformers, according to its stock exchange notification.

CG Power trades at 53 times its estimated earnings per share, Bloomberg data showed. The stock is 1.2 percent below the Bloomberg consensus one-year price target.

• There was a 91 percent increase in copra prices.
• We have not passed on these prices to consumers.
• We have put in place an aggressive cost management program to offset the rise in copra prices.
• Copra has peaked out, and we expect copra prices to soften going ahead.
• We continue to focus on volumes growth and market share.
• We have had a 9 percent growth on constant currency basis in the international business.
• All geographies except for Vietnam have given double-digit growth.
• We have diagnosed some of the issues we have to solve in Saffola.

Shares of the agricultural holding company rose as much as 11.9 percent, the most in four-and-a-half months to Rs 552.45. The company reported more than a 11-fold jump in its net profit during December quarter.

Key Earnings Highlights Q3 (YoY)

• Net profit rose 1,016 percent to Rs 48 crore.
• Revenue rose 46.3 percent to Rs 1,434 crore.
• Ebitda rose 34.6 percent to Rs 125.7 crore.
• Margins contracted to 8.8 percent versus 9.5 percent.

Apcotex Industries

• Stock rose as much as 21.1 percent to Rs 562.35.
• Trading volume was 28.4 times its 200-day average.

Vadilal Industries

• Stock rose as much as 14.6 percent to Rs 971.45.
• Trading volume was 11.2 times its 20-day average.

3M India

• Stock rose as much as 20 percent to Rs 22,709.30.
• Trading volume was 10.9 times its 20-day average.

Honeywell Automation India

• Stock rose as much as 10.9 percent to Rs 18,832.
• Trading volume was 5.4 times its 20-day average.

KNR Constructions

• Stock rose as much as 9.8 percent to Rs 340.
• Trading volume was 3.3 times its 20-day average.

#AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment choice — be it in equities, commodities or the derivatives markets.

Here’s how you can get your queries answered:

• Tweet us your queries using #AskBQ
• WhatsApp us on +91-8291229686
• Call us on 022-45404141
• Email us on askbq@bloombergquint.com

Watch the full conversation here:

Shares of the pharmaceutical company extended gains for the second trading session and rose as much as 4.6 percent, the most in two weeks to Rs 4,943.95. The company announced that it introduced new insulin drug 'Toujeo' in the Indian market.

Trading volume was 2.6 times its 30-day average. The stock returned 3.1 percent so far this year compared to 0.5 percent advance in Sensex.

Coal India Q3 (YoY)

• Stock rose as much as 1.6 percent to Rs 305.
• Revenue up 5 percent at Rs 20,708.47 crore.
• Net Profit up 4.21 percent to Rs 3004.8 crore.
• EBITDA up 18.23 percent to Rs 4,617.9 crore.
• EBITDA Margin at 21.3 percent versus 19.08 percent.

Tata Steel Q3 (YoY)

• Stock rose as much as 4.7 percent to Rs 718.
• Revenue up 21 percent at Rs 33,447 crore.
• Net profit up 433 percent at Rs 1,294 crore.
• EBITDA up 57 percent at 5,697 crore.
• Margins at 17 percent versus 13.1 percent.

Mahindra & Mahindra Q3 (YoY)

• Stock rose as much as 2.7 percent to Rs 770.
• Revenue up 10.3 percent at Rs 11,491.5 crore.
• Net Profit up 16.8 percent at Rs 1305 crore.
• EBITDA up 19.6 percent at Rs 1693 crore.
• Margins 14.73 percent versus 13.6 percent.

SBI Q3 (QoQ)

• Stock fell as much as 1.4 percent to Rs 292.40.
• NII flat at Rs 18,688 crore.
• Net Loss at Rs 2417 crore versus net profit of Rs 1581.5 crore.
• Domestic NIM at 2.61 percent.
• GNPA at 10.35 percent.
• NNPA at 5.61 percent.

BPCL Q3 (QoQ)

• Stock fell as much as 2.5 percent to Rs 463.65.
• Revenue up 13.7 percent at Rs 60,616.4 crore.
• Net Profit down 9.1 percent at Rs 2144 crore.
• EBITDA down 9.6 percent at Rs 3188 crore.
• Margins at 5.3 percent versus 6.6 percent.

ONGC Q3 (QoQ)

• Stock rose as much as 3.8 percent to Rs 194.50.
• Revenue 21.3 percent At Rs 22,996 crore.
• Net Profit down 2.3 percent at Rs 5015 crore.
• EBITDA up 19.5 percent at Rs 10,919 crore.
• Margins at 47.5 percent versus 48.2 percent.

Key highlights from the conversation:

• In next 3-5 years, hospital business expansion will start playing out.
• Return on capital in pharmacies will be very high due to low capex model.
• See more revenues coming in from hospitals going forward.
• Going forward, we see ramp up of these units, as of now units have break-even.
• Opened 25-30 labs which pulled down operating income, but now we are reaping benefits.
• 18 percent income come from India, 82 percent from GCC.
• Expect 35 percent business from india over next 3-5 years.

Shares of the country's largest drug marker rose as much as 4.5 percent to Rs 608.95, its highest in nearly nine months. The USFDA is said to start an inspection of Sun Pharma’s Halol plant, sources told BloombergQuint on the condition of anonymity.

The stock trades at 29.9 times its estimated forward earnings per share, compared to 23.8 times for the two-year historical average.

Shares of the auto part maker extended gains for the fourth trading session and rose as much as 5 percent to Rs 1,116.

The company won an order for the supply of steel wheels from Europe, according to its stock exchange notification. The stock fell 7.8 percent in the past month, compared to 1.3 percent decline in Sensex.

Shares of the pharmaceutical company rose as much as 5.4 percent to Rs 434. The U.S. drug regulator completed inspection at its key Moraiya facility, and that there were no concerns found during the inspection, according to its stock exchange notification.

The stock was the best performer on Nifty Pharma Index. Trading volume was 12.9 times the 30-day average. Last week, the U.S. drug regulator had conducted a surprise audit at the company’s largest Moraiya plant, after multiple recalls of a drug made at the unit.

• TCS: About 11 lakh shares changed hands in a block deal.

Buyers and sellers were not known immediately

Source: Bloomberg

Shares of the construction major rose as much as 1.5 percent to Rs 1,348. The engineering giant singed EPC contract worth more than 2,200 crore with Abu Dhabi-based Al Dhafra Petroleum Operations, according to its stock exchange notification.

The scope of the contract includes engineering, procurement, construction and commissioning of flow lines, gathering facilities and pipelines to transfer crude oil and gas, and installation of 132 kilo-volts and 33 kilo-volts overhead electrical transmission lines to supply power, the exchange notification added.

L&T trades at 30.5 times trailing 12-month earnings per share and 27 times its estimates for the coming year, Bloomberg data showed. The stock returned 6.8 times since the beginning of the year.

Indian equity benchmarks rebounded after posting their worst two week losses since in two years. The S&P BSE Sensex index rose as much as 0.7 percent to 34,269.18, while the NSE Nifty 50 index rose as much as 0.8 percent to 10,538.10.

The market breadth was tilted in favour of buyers. All the 19 sector gauges compiled by BSE Ltd. rose, led by S&P BSE Realty Index's 1.5 percent gain.

• Indian Rupee is likely to advance after the region's equities traded higher, following back-to-back weekly losses.
• The Sovereign bond, on the other hand, will be focused on the release on India's consumer price index later today.

• Nifty February futures trade at 10,469.7 premium of 14.8 points versus discount of 3.7 points.
• February series-Nifty open interest up 7 percent , Bank Nifty open interest down 3 percent.
• India VIX ended at 19.2, up 8.2 percent.
• Max open interest for February series at 11,100 call strike , open interest at 57.6 lakh, open interest down 1 percent.
• Max open interest for February series at 10,000 Put, open interest at 57.6 lakh, up 3 percent.

F&O Ban

• In ban: Balrampur Chini Mills, GMR Infrastructure, HDIL, Jain Irrigation.
• Out of ban: Fortis Healthcare
• Only intraday positions can be taken in stocks which are in F&O ban. There is penalty in case of rollover of these intraday positions.

Put-Call Ratio

• Nifty PCR unchanged at 1.09.
• Nifty Bank PCR at 0.96 versus 0.87.

Deutsche Bank on ONGC

• Maintained ‘Buy’ with price target of Rs 250.
• December quarter’s net profit was below estimates; Ebitda remained inline.
• Non-operating costs drag down profits.
• Other expenses increased due to higher workover expenses.
• Valuations still inexpensive.
• Expect earnings per share to compound at 11 percent through the financial years till March 2020.

Nomura on ONGC

• Maintained ‘Neutral’ with price target of Rs 200.
• December quarter’s Ebitda and net profit were below estimates.
• Weak result driven by higher opex and depletion charges.
• Near-term gas production to increase from Vashistha field.
• Expect dividend announcement in next few weeks.
• Continue to prefer OMCs over upstream; Pecking order IOCL > BPCL > HPCL.

Deutsche Bank on BPCL

• Maintained ‘Buy’ with price target of Rs 645.
• December quarter’s net profit and Ebitda were below estimates.
• Lower than expected inventory gains, higher other expenses depreciation impacted quarter.
• Marketing segment performance should improve in current quarter.

Motilal Oswal on BPCL

• Maintained ‘Buy’ with price target of Rs 549.
• Ebitda significantly below estimate.
• Kochi refinery expansion is yet to stabilise.
• Pressure seen on marketing margins as commensurate price hikes not taken.
• Current decline in oil provides ample room for normalisation of margins.

IDFC Securities on HPCL

• Maintained ‘Outperform’ with price target of Rs 515.
• Inventory gains more than offset muted margins.
• Excluding inventory gains, core refining metrics were weak.
• Marketing earnings and volumes weak for the quarter.
• Miss on margins notwithstanding HPCL’s positive prospects over the financial years through March 2020.

Deutsche Bank on HPCL

• Maintained ‘Buy’ with price target of Rs 535.
• December quarter’s net profit was above estimates.
• Higher-than-expected refining margin and inventory gains aided December quarter.
• Inventory gains offset weak marketing margins.
• Increase in margins since Jan to help marketing operating income in current quarter.

Edelweiss on SBI

• Maintained ‘Buy’ with price target of Rs 420 from Rs 399
• December quarter’s performance disappointed in terms of revenue & slippage.
• Slippages high, but overall stress pool contained.
• Divergence and investment depreciation play spoilsport.
• Operating metrics seem to have bottomed out this quarter.
• Expect NIM to sustain or improve from current levels.

JPMorgan on SBI

• Maintained ‘Neutral’ with price target of Rs 320.
• December quarter results missed on asset quality and treasury.
• Slippages were up due to NPA divergence arising from RBI inspection report.
• Loan growth remained subdued due to contraction of corporate loan book.
• Expect weak set of results to remain an overhang on the stock in near term.

Macquarie on Tata Steel

• Upgraded to ‘Outperform’ from ‘Underperform’; raised price target to Rs 800 from Rs 572.
• December quarter’s operating income above estimates led by strong margins in India.
• Strong India results partially offset by weak margins in Europe.
• Buoyant steel market fixes balance sheet.
• Stronger balance sheet + focus on domestic growth => Re-rating.
• Witnessing price tailwinds as steel market remains resilient.
• Rights issue to address leverage issues and growth capital.

JPMorgan on Tata Steel

• Maintained ‘Overweight’ with price target of Rs 1,015.
• December quarter reported highest ever India EBITDA; PAT impacted by provisions.
• TATA Europe lower seasonally weak quarter.
• TATA ideally positioned in the current upturn in steel environment.
• Stressed Asset Auction: TATA is among the lower bids so far.
• Q4 should see higher margins, but volumes in India could be impacted.
• Steel environment remains very supportive.

Jefferies on Mahindra and Mahindra

• Maintained ‘Hold’; raised price target to Rs 820 from Rs 757
• December quarter’s operating income missed slightly, led by better gross margins
• Better rural demand should support growth and margins in the next financial year.
• Structural issues in UV business could worsen post BS-VI implementation.
• Expect a downturn in tractor cycle in the financial year ending-March 2020 post three years of up-cycle
• Expect domestic tractor volume growth of 18 percent, 10 percent and -10 percent respectively over the current and next two financial years respectively.

Motilal Oswal on Mahindra and Mahindra

• Maintained ‘Buy’ with price target of Rs 889.
• Operating performance miss led by higher other expense.
• Volume and realization growth drives revenues.
• Higher other expense dent operating income.
• High other income, low interest and depreciation support bottomline.
• Expect strong growth in tractor volumes on the back of normal monsoon.
• Expect passenger UVs to benefit from rural recovery and new launches.

Deutsche Bank on Marico

• Maintained ‘Buy’ with price target of Rs 350.
• Marico has once again navigated the downturn well.
• Preference for volumes and market share over margins continues.
• Price hikes in Parachute will still not cover the sharp rise in Copra.
• Wholesale and rural largely recovered; Initial signs of shift to organised is visible.
• E-way bill may bring medium-term disruptions in the wholesale channel.

JPMorgan on Marico

• Maintained ‘Neutral’ with price target of Rs 330.
• December quarter beat led by Parachute; VAHO/Saffola disappoint.
• Coconut Oil – Share gains drive strong performance.
• Male Grooming – Good performance.
• EBITDA margin performance above expectations led by sales and lower A&P.
• Copra inflation continues to weigh on gross margins.

Macquarie on Sun TV

• Maintained ‘Outperform’; raised price target to Rs 1,132 from Rs 956.
• Ad growth at multi-quarter high.
• Digitisation in Tamil Nadu picking up gradually.
• Gearing to make its first non-south foray in the next fiscal.
• Expect ad outlook to improve and subscription uptick in TN.
• Upcoming launch of Colors Tamil is a key monitorable.

Axis Capital on Sun TV

• Maintained ‘Buy’ with price target of Rs 1,280.
• December quarter’s ad revenue saw strong growth across its four languages.
• Healthy volumes and improved yield on market share gains led previous quarter.
• Believe worst is behind for Sun TV.
• Sun to benefit from revival in ad spends, strong subscription and turnaround in IPL.

Morgan Stanley on Bank of Baroda

• Maintained ‘Equal-weight’ with price target of Rs 195.
• December quarter missed driven by higher NPA provisions partially offset by higher PPoP.
• Key surprise was margins at 2.72 percent versus 2.31 percent last quarter.
• Await details on the impact on net interest.

Motilal Oswal on Bank of Baroda

• Maintained ‘Buy’ with price target of Rs 185.
• Strong operational performance; Stressed assets declining rapidly.
• NII growth led by traction in loan growth, improvement in domestic CASA mix, slower growth in low-margin international business and improvement in asset mix.
• Slippages were elevated due to slippages from restructured book.
• Near-term earnings volatility likely to continue.
• Expect stress addition and credit costs to moderate from the next fiscal.

Deutsche Bank on Oil India

• Maintained ‘Buy’ with price target of Rs 455.
• December quarter’s net profit and operating income was below due to high other expenses and low other income.
• Oil India benefiting from higher oil price.
• Expect higher oil net realisation driven by rise in global oil prices.
• Expect production to grow driven by supplies to Assam Gas cracker.

Jefferies on Oil India

• Maintained ‘Buy’ with price target of Rs 465.
• December quarter’s a good quarter with EBITDA above estimates.
• Lower opex and higher LPG revenues with production steady QoQ.
• Higher oil prices bring higher subsidies; Govt.'s next fiscal’s subsidy budget is inadequate.
• Subsidies are key risk but keep Buy noting inexpensive valuations.

Macquarie on Strides Shasun

• Maintained ‘Outperform’; cut price target to Rs 996 from Rs 1,100.
• Previous quarter saw an uptick in both the U.S. and Australia.
• New launches picking up well.
• Australia to be a key margin driver.
• EM & Institutional business to recover in the next quarter.
• Continue to like Strides and believe a continued revenue uptick in regulated markets.
• Expect earnings momentum to pick up in the next fiscal.

IDFC Securities on Strides Shasun

• Maintained ‘Outperformer’; cut price target to Rs 976.
• December quarter was weak, Institutional segment drags.
• Inline regulated market revenues and GMs.
• Sharply lower institutional revenues and other income.
• Expect pickup in EBITDA growth to drive earnings growth from next fiscal onwards.
• Remains positive on the growth potential of the new entity.

Motilal Oswal on Mahanagar Gas

• Upgraded to ‘Buy’ from ‘Neutral’; raised price target to Rs 1,228.
• December quarter’s operating income was above estimate.
• Operating income beat led by higher volumes and lower opex.
• Expect 6 percent and 8 percent volume growth in the next two fiscal.
• Current EBITDA/scm not sustainable; Expect EBITDA/scm of Rs 7.5/7 in the next two fiscal.
• Expect operating income and warnings per share to compound at 7 percent each over the financial years till March 2020.

Morgan Stanley on Aditya Birla Capital

• Maintained ‘Equal-weight’ with price target of Rs 185.
• Growth trends were strong across businesses.
• Miss on estimates driven by higher costs on account.
• NBFC - Some moderation in growth momentum and NIM; Rise in NPLs.

Axis Capital on Bata India

• Upgraded to ‘Buy’ from ‘Hold’; raised price target to Rs 825 from Rs 725.
• December quarter was above estimates supported by change in mix towards higher ASP products.
• New launches, strong marketing campaigns to drive sales growth.
• Higher thrust on comfort and fashion to aid product mix and improve profitability.
• Expect Bata to benefit in the GST era.

Axis Capital on Alkem Laboratories

• Maintained ‘Buy’ with price target of Rs 2,500.
• Strong gross margin and higher India and U.S. sales led to operating income beat
• Strong India growth on channel restocking; Scale-up in U.S. on track.
• Expect tax rate to normalize to 18 percent in the next fiscal.
• Expect strong growth in India sales given strong positioning.
• Ramp-up in the U.S. to drive operating leverage.
• Expect cumulative FCF generation of Rs 960 crore over the next two financial years.

IDFC Securities on Suzlon

• Maintained ‘Outperform’ with price target of Rs 21.
• Strong execution in a challenging environment.
• Execution improved with Feed in Tariff PPAs getting approval.
• Believe Suzlon’s better product portfolio to help company.
• Strong order book and framework agreement bodes well.
• Expect strong execution and earnings recovery in the next fiscal.

Motilal Oswal on Coal India

• Maintain buy with TP of Rs 401.
• Q3FY18: In-line; e-auction offset drag of power sector priority.
• E-auction realization surprised positively, increasing 24 percent QoQ.
• Concerns around grade slippage and wage hike are now behind.
• Believe coal will continue to be the key fuel for electricity generation.
• Expect Coal India to achieve 6-7 percent volume growth.
• Expect earnings to compound at 30 percent over the financial years through March 2020.
• Valuations are attractive with 5-8 percent dividend yield.

Coal India Q3 (YoY)

• Revenue up 5 percent at Rs 20,708.47 crore.
• Net Profit up 4.21 percent to Rs 3004.8 crore.
• EBITDA up 18.23 percent to Rs 4,617.9 crore.
• EBITDA Margin at 21.3 percent versus 19.08 percent.

Tata Steel Q3 (YoY)

• Revenue up 21 percent at Rs 33,447 crore.
• Net profit up 433 percent at Rs 1,294 crore.
• EBITDA up 57 percent at 5,697 crore.
• Margins at 17 percent versus 13.1 percent.

Bata India Q3 (YoY)

• Revenue up 6 percent at Rs 674 crore.
• Net profit up 79 percent at Rs 68 crore.
• EBITDA up 42 percent at Rs 112 crore.
• Margins at 16.6 percent versus 12.4 percent.

Himatsingka Seide Q3 (YoY)

• Revenue up 9 percent at Rs 596 crore.
• Net profit up 11 percent at Rs 50 crore.
• EBITDA up 26 percent at Rs 117 crore.
• Margins at 19.6 percent versus 16.9 percent.

Sun TV Network Q3 (YoY)

• Revenue up 16 percent at Rs 683 crore.
• Net profit up 11 percent at Rs 267 crore.
• EBITDA up 12 percent at Rs 492 crore.
• Margins at 72 percent versus 74.6 percent.

Avanti Feeds Q3 (YoY)

• Revenue up 32 percent at Rs 706 crore.
• Net Profit up 98 percent at Rs 100.5 crore.
• EBITDA up 123 percent at Rs 154 crore.
• Margins at 21.7 percent versus 12.9 percent.

Centrum Capital Q3 (YoY)

• Total Income up 4 percent at Rs 26.9 crore.
• Net Profit up 182 percent at Rs 6 crore.

Sobha Q3 (YoY)

• Revenue up 27 percent at Rs 692 crore.
• Net Profit up 64 percent at Rs 53.4 crore.
• EBITDA up 43 percent at Rs 137.5 crore.
• Margins at 19.9 percent versus 17.9 percent.

National Aluminium Co. Q3 (YoY)

• Revenue up 20 percent at Rs 2389 crore.
• Net Profit up 401.5 percent at Rs 722 crore.
• EBITDA up 20.5 percent at Rs 344 crore.
• Margins at 14.4 percent versus 14.3 percent.

Mahindra & Mahindra Q3 (YoY)

• Revenue up 10.3 percent at Rs 11,491.5 crore.
• Net Profit up 16.8 percent at Rs 1305 crore.
• EBITDA up 19.6 percent at Rs 1693 crore.
• Margins 14.73 percent versus 13.6 percent.

Marico Q3 (YoY)

• Revenue up 15 percent at Rs 1624 crore.
• Net profit up 17 percent at Rs 220.5 crore.
• EBITDA up 8 percent at Rs 319 crore.
• Margins at 19.4 percent versus 20.6 percent.

Capacite Infraprojects Q3 (YoY)

• Revenue up 16 percent at Rs 366.5 crore.
• Net profit up 40 percent at Rs 22.7 crore.
• EBITDA up 9 percent at Rs 50 crore.
• Margins at 13.6 percent versus 14.4 percent.

Mahanagar Gas Q3 (QoQ)

• Net Sales up 9 percent at Rs 581 crore.
• Net profit down 0.6 percent at Rs 124 crore.
• EBITDA flat at Rs 201 crore.
• Margins at 34.6 percent versus 37.6 percent.

Oil India Q3 (QoQ)

• Revenue up 15.3 percent at Rs 2853 crore.
• Net Profit up 9 percent at Rs 705.2 crore.
• EBITDA down 21 percent at Rs 1224.5 crore.
• Margins at 42.9 percent versus 40.9 percent.

SBI Q3 (QoQ)

• NII flat at Rs 18,688 crore.
• Net Loss at Rs 2417 crore versus net profit of Rs 1581.5 crore.
• Domestic NIM at 2.61 percent.
• GNPA at 10.35 percent.
• NNPA at 5.61 percent.

Bank of Baroda Q3 (YoY)

• NII up 40 percent at Rs 4,394 crore.
• Net Profit down 56 percent at Rs 111.8 crore.
• NIM at 2.72 percent versus 2.31 percent (QoQ)
• GNPA at 11.31 percent versus 11.16 percent (QoQ)
• NNPA at 4.97 percent versus 5.05 percent (QoQ)

BPCL Q3 (QoQ)

• Revenue up 13.7 percent at Rs 60,616.4 crore.
• Net Profit down 9.1 percent at Rs 2144 crore.
• EBITDA down 9.6 percent at Rs 3188 crore.
• Margins at 5.3 percent versus 6.6 percent.

ONGC Q3 (QoQ)

• Revenue 21.3 percent At Rs 22,996 crore.
• Net Profit down 2.3 percent at Rs 5015 crore.
• EBITDA up 19.5 percent at Rs 10,919 crore.
• Margins at 47.5 percent versus 48.2 percent.

Kitex Garments Q3 (YoY)

• Revenue up 3.5 percent at Rs 147 crore.
• Net profit down 45 percent at Rs 17.6 crore.
• EBITDA down 24 percent at Rs 36.7 crore.
• Margins at 24.9 percent versus 34.1 percent.

SJVN Q3 (YoY)

• Revenue down 12 percent at Rs 437 crore.
• Net profit down 21 percent at Rs 206 crore.
• EBITDA down 22 percent at Rs 300 crore.
• Margins at 68.6 percent versus 77.6 percent.

Apex Frozen Foods Q3 (QoQ)

• Revenue down 8 percent at Rs 263 crore.
• Net profit down 15 percent at Rs 19 crore.
• EBITDA down 3 percent at Rs 30 crore.
• Margins at 11.4 percent versus 10.8 percent.

Suzlon Energy Q3 (YoY)

• Revenue down 33.5 percent at Rs 2204 crore.
• Net Loss at Rs 28 crore versus net profit of Rs 282.5 crore.
• EBITDA down 69 percent at Rs 231 crore.
• Margins at 10.5 percent versus 22.4 percent.

Syndicate Bank Q3 (YoY)

• NII up 17 percent at Rs 1623.2 crore.
• Net Loss at Rs 869.8 crore versus net profit of Rs 93.6 crore.
• GNPA at 9.62 percent versus 9.39 percent (QoQ).
• NNPA at 5.44 percent versus 5.76 percent (QoQ).

MOIL Q3 (YoY)

• Revenue down 16 percent at Rs 300 crore.
• Net Profit up 2.3 percent at Rs 103.8 crore.
• EBITDA down 6 percent at Rs 123 crore.
• Margins at 41 percent versus 36.8 percent.

Meghamani Organics Q3 (YoY)

• Revenue up 40.4 percent at Rs 450.43 crore.
• Net profit up 130.9 percent at Rs 62.61 crore.
• EBITDA up 93.4 percent at Rs 117.2 crore.
• Margins at 26 percent versus 18.9 percent.

Kesoram Industries Q3 (YoY)

• Revenue up 0.74 percent at Rs 883.01 crore.
• Net loss at Rs 43.17 crore versus net loss of Rs 74.67 crore.
• EBITDA loss at Rs 26.4 crore versus EBITDA profit of Rs 9.6 crore.
• Margins at -3 percent vs 1.1 percent.
• Other income at Rs 158.2 crore versus Rs 18.72 crore.

Wonderla Holidays Q3 (YoY)

• Revenue down 6.4 percent at Rs 63.8 crore.
• Net profit up 49 percent at Rs 6.5 crore.
• EBITDA up 58.4 percent at Rs 19.1 crore.
• Margins at 29.9 percent versus 17.6 percent.

Atul Auto Q3 (YoY)

• Revenue down 4.3 percent at Rs 129.0 crore.
• Net profit down 19.7 percent at Rs 9.7 crore.
• EBITDA down 17.3 percent at Rs 15.6 crore.
• Margins at 12.1 percent versus 13.9 percent.

Great Eastern Shipping Company Q3 (YoY)

• Revenue up 20.3 percent at Rs 864.7 crore.
• Net profit at Rs 30.06 crore versus net loss of Rs 2.6 crore.
• EBITDA down 2.2 percent at Rs 77.67 crore.
• Margins at 9.0 percent versus 11.1 percent.

VA Tech Wabag Q3 (YoY)

• Revenue up 20.3 percent at Rs 864.7 crore.
• Net profit at Rs 30.06 crore versus net loss of Rs 2.56 crore.
• EBITDA down by 2.2 percent at Rs 77.67 crore.
• Margins at 8.9 percent versus 11.1 percent.

Ramky Infrastructure Q3 (YoY)

• Revenue down 31.2 percent at Rs 256.8 crore.
• Net profit down 96.8 percent at Rs 0.86 crore.
• EBITDA loss at Rs 68.33 crore versus Rs 107.93 crore.
• Margins at -26.6 percent versus 28.9 percent.

• Bank of India
• Britannia Industries
• CG Power And Industrial Solutions
• Corporation Bank
• Eris Lifesciences
• General Insurance Corporation of India
• Glaxosmithkline Consumer
• Indian Bank
• Indian Hotels
• J Kumar Infraprojects
• JK Tyre
• MEP Infra
• Power Finance Corporation
• SCI
• UFO Moviez India
• United Bank of India

• GAIL India

• Claris Lifesciences acquisition window from Feb12 to Feb. 20.
• Galaxy Surfactants added to BSE IPO Index.
• Gujarat NRE Coke suspended from trading.

• Avadh Sugar & Energy: Anil Kumar Goel bought 54,000 shares or 0.5 percent equity at Rs 789.7 each.
• Fortis Healthcare: Societe Generale bought 38.11 lakh shares or 0.7 percent equity at Rs 141.53 each.

• ONGC Videsh led Indian Consortium comprising of ONGC Videsh, Indian Oil Corporation Limited and Bharat Petro Resources Limited to acquire 10 percent stake in Lower Zakum Concession, Offshore Abu Dhabi for $600 million. Indian Consortium annual share shall be about 2 MMT.
• Cadila Healthcare's Moraiya facility successfully completes U.S. FDA inspection
• Ajanta Pharma’s formulation facility at Dahej was inspected by U.S. FDA from Feb. 5-9. Form 483 was not issued by the FDA.
• Fortis Healthcare says it is still evaluating fund raising options.
• Tata Motors Group global wholesales at 114,797 in January 2018.
• NMDC total production and sales until Jan. 31 at 27.87 million tonnes and 28.89 million tonnes respectively.
• UCO Bank to allot preferential shares to government against infusion of Rs 5,130 crore.
• Dredging Corp secures Rs 30.76 crore contract for dredging of naval sites at Mumbai.

• GST return simplification panel to meet industry this week.
• PM meets Crown Prince of Abu Dhabi; India, UAE sign 5 pacts.
• RBI to have additional instrument for liquidity management.
• EV sales to see double-digit growth till 2020: Report.
• National Health Insurance Plan challenging but achievable.
• Modi’s call for simultaneous polls may signal early elections.

• West Texas Intermediate crude was little changed at $59.18 a barrel. It slumped 9.6 percent last week.
• Gold was steady at $1,316.10 an ounce.
• Brent crude inched higher by 0.06 percent to trade at 62.8 per barrel.
• Sugar ended lower for second day at 13.55 cents per pound; down 0.3 percent.

Shanghai Exchange

• Steel trades lower for fourth day; down 0.6 percent.
• Aluminium trades lower for second day; down 0.8 percent.
• Zinc trades lower; down 0.7 percent.
• Copper trades lower for fourth day; down 1.4 percent.
• Rubber snaps nine-day losing streak; up 0.1 percent.

Good Morning!

The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, rose 0.3 percent to 10,487.50 as of 8:25 a.m.

Investors got a reprieve from the recent turmoil with Asian stocks recovering from their worst weekly rout since 2011 as volatility swept global markets.